TNYA

Tenaya Therapeutics, Inc.

Insider trading activity for Tenaya Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$21K

net selling

Bought(0 · 0 insiders): $0
Sold(8 · 2 insiders): $21K

Past 6 months

-$27.4K

net selling

Bought(0 · 0 insiders): $0
Sold(11 · 3 insiders): $27.4K

Past 12 months

-$6M

net selling

Bought(0 · 0 insiders): $0
Sold(35 · 4 insiders): $6M

Transaction history

The 73 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 10	Tingley Whittemore	Chief Medical Officer	AGRANT◆	293,000	—	—	—	Open the original filing on SEC.gov
Sep 10	Tingley Whittemore	Chief Medical Officer	AGRANT	49,000	—	—	+22.9%	Open the original filing on SEC.gov
Sep 10	Ali Faraz	Chief Executive Officer	AGRANT◆	732,500	—	—	—	Open the original filing on SEC.gov
Sep 10	Ali Faraz	Chief Executive Officer	AGRANT	122,000	—	—	+29.2%	Open the original filing on SEC.gov
Aug 17	Ali Faraz	Chief Executive Officer	SSELL	7,406	$0.7097	$5.3K	-1.7%	Open the original filing on SEC.gov
Aug 17	Ali Faraz	Chief Executive Officer	SSELL	5,020	$0.7097	$3.6K	-1.2%	Open the original filing on SEC.gov
Aug 17	Ali Faraz	Chief Executive Officer	SSELL	3,969	$0.7098	$2.8K	-0.9%	Open the original filing on SEC.gov
Aug 17	Ali Faraz	Chief Executive Officer	SSELL	5,837	$0.7097	$4.1K	-1.3%	Open the original filing on SEC.gov
Aug 17	Tingley Whittemore	Chief Medical Officer	SSELL	2,279	$0.7098	$1.6K	-1.1%	Open the original filing on SEC.gov
Aug 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,871	$0.7098	$1.3K	-0.9%	Open the original filing on SEC.gov
Aug 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,637	$0.7098	$1.2K	-0.7%	Open the original filing on SEC.gov
Aug 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,637	$0.7098	$1.2K	-0.7%	Open the original filing on SEC.gov
Jul 13	Hyllengren Eric J	Chief Financial Officer	AGRANT◆	1.7M	—	—	—	Open the original filing on SEC.gov
May 28	Williams R Sanders	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Walsh Jeffrey T.	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Stehman-Breen Catherine	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Srivastava Deepak	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Parschauer Karah Herdman	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Lee June	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 28	Burroughs Amy L.	Director	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
May 18	Tingley Whittemore	Chief Medical Officer	SSELL	3,121	$0.7936	$2.5K	-1.4%	Open the original filing on SEC.gov
May 18	Higa Tomohiro	SVP, Finance	SSELL	1,485	$0.7932	$1.2K	-1.2%	Open the original filing on SEC.gov
May 18	Ali Faraz	Chief Executive Officer	SSELL	3,390	$0.7934	$2.7K	-0.8%	Open the original filing on SEC.gov
Feb 25	Column Group III Gp, Lp	10% Owner	SSELL	1.9M	$0.5624	$1M	-100.0%	Open the original filing on SEC.gov
Feb 25	Column Group III Gp, Lp	10% Owner	SSELL	1.6M	$0.5624	$927.6K	-100.0%	Open the original filing on SEC.gov
Feb 24	Column Group III Gp, Lp	10% Owner	SSELL	349,212	$0.6153	$214.9K	-15.8%	Open the original filing on SEC.gov
Feb 24	Column Group III Gp, Lp	10% Owner	SSELL	309,228	$0.6153	$190.3K	-15.8%	Open the original filing on SEC.gov
Feb 23	Column Group III Gp, Lp	10% Owner	SSELL	162,291	$0.5972	$96.9K	-6.8%	Open the original filing on SEC.gov
Feb 23	Column Group III Gp, Lp	10% Owner	SSELL	143,709	$0.5972	$85.8K	-6.8%	Open the original filing on SEC.gov
Feb 20	Column Group III Gp, Lp	10% Owner	SSELL	277,769	$0.6149	$170.8K	-10.5%	Open the original filing on SEC.gov
Feb 20	Column Group III Gp, Lp	10% Owner	SSELL	245,965	$0.6149	$151.2K	-10.5%	Open the original filing on SEC.gov
Feb 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,876	$0.6431	$1.2K	-0.9%	Open the original filing on SEC.gov
Feb 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,642	$0.6432	$1.1K	-0.7%	Open the original filing on SEC.gov
Feb 17	Tingley Whittemore	Chief Medical Officer	SSELL	1,642	$0.6432	$1.1K	-0.7%	Open the original filing on SEC.gov
Feb 17	Higa Tomohiro	SVP, Finance	SSELL	2,022	$0.6431	$1.3K	-1.7%	Open the original filing on SEC.gov
Feb 17	Higa Tomohiro	SVP, Finance	SSELL	836	$0.6434	$538	-0.7%	Open the original filing on SEC.gov
Feb 17	Higa Tomohiro	SVP, Finance	SSELL	611	$0.6434	$393	-0.5%	Open the original filing on SEC.gov
Feb 17	Ali Faraz	Chief Executive Officer	SSELL	5,032	$0.643	$3.2K	-1.1%	Open the original filing on SEC.gov
Feb 17	Ali Faraz	Chief Executive Officer	SSELL	3,979	$0.6431	$2.6K	-0.9%	Open the original filing on SEC.gov
Feb 17	Ali Faraz	Chief Executive Officer	SSELL	5,851	$0.643	$3.8K	-1.3%	Open the original filing on SEC.gov
Feb 11	Column Group III Gp, Lp	10% Owner	SSELL	2.2M	$0.6808	$1.5M	-44.8%	Open the original filing on SEC.gov
Feb 11	Column Group III Gp, Lp	10% Owner	SSELL	1.9M	$0.6808	$1.3M	-44.8%	Open the original filing on SEC.gov
Feb 10	Column Group III Gp, Lp	10% Owner	SSELL	182,295	$0.8161	$148.8K	-3.7%	Open the original filing on SEC.gov
Feb 10	Column Group III Gp, Lp	10% Owner	SSELL	161,422	$0.8161	$131.7K	-3.7%	Open the original filing on SEC.gov
Feb 3	Tingley Whittemore	Chief Medical Officer	AGRANT◆	318,500	—	—	—	Open the original filing on SEC.gov
Feb 3	Tingley Whittemore	Chief Medical Officer	AGRANT	48,750	—	—	+27.9%	Open the original filing on SEC.gov
Feb 3	Higa Tomohiro	SVP, Finance	AGRANT◆	175,500	—	—	—	Open the original filing on SEC.gov
Feb 3	Higa Tomohiro	SVP, Finance	AGRANT	29,250	—	—	+31.1%	Open the original filing on SEC.gov
Feb 3	Ali Faraz	Chief Executive Officer	AGRANT◆	952,250	—	—	—	Open the original filing on SEC.gov
Feb 3	Ali Faraz	Chief Executive Officer	AGRANT	158,600	—	—	+52.9%	Open the original filing on SEC.gov
Nov 17, 2025	Tingley Whittemore	Chief Medical Officer	SSELL	2,877	$1.33	$3.8K	-1.7%	Open the original filing on SEC.gov
Nov 17, 2025	Higa Tomohiro	SVP, Finance	SSELL	1,367	$1.33	$1.8K	-1.4%	Open the original filing on SEC.gov
Nov 17, 2025	Ali Faraz	Chief Executive Officer	SSELL	3,126	$1.33	$4.2K	-1.0%	Open the original filing on SEC.gov
Aug 18, 2025	Tingley Whittemore	Chief Medical Officer	SSELL	1,837	$1.25	$2.3K	-1.1%	Open the original filing on SEC.gov
Aug 18, 2025	Tingley Whittemore	Chief Medical Officer	SSELL	1,608	$1.25	$2K	-0.9%	Open the original filing on SEC.gov
Aug 18, 2025	Tingley Whittemore	Chief Medical Officer	SSELL	1,608	$1.25	$2K	-0.9%	Open the original filing on SEC.gov
Aug 18, 2025	Higa Tomohiro	SVP, Finance	SSELL	1,722	$1.25	$2.2K	-1.8%	Open the original filing on SEC.gov
Aug 18, 2025	Higa Tomohiro	SVP, Finance	SSELL	717	$1.25	$898	-0.7%	Open the original filing on SEC.gov
Aug 18, 2025	Higa Tomohiro	SVP, Finance	SSELL	523	$1.25	$655	-0.5%	Open the original filing on SEC.gov
Aug 18, 2025	Ali Faraz	Chief Executive Officer	SSELL	4,920	$1.25	$6.2K	-1.6%	Open the original filing on SEC.gov
Aug 18, 2025	Ali Faraz	Chief Executive Officer	SSELL	3,893	$1.25	$4.9K	-1.3%	Open the original filing on SEC.gov
Aug 18, 2025	Ali Faraz	Chief Executive Officer	SSELL	5,720	$1.25	$7.2K	-1.8%	Open the original filing on SEC.gov
May 29, 2025	Walsh Jeffrey T.	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Williams R Sanders	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Stehman-Breen Catherine	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Srivastava Deepak	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Parschauer Karah Herdman	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Lee June	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Goeddel David V	Director, 10% Owner	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 29, 2025	Burroughs Amy L.	Director	AGRANT◆	107,400	—	—	—	Open the original filing on SEC.gov
May 16, 2025	Tingley Whittemore	Chief Medical Officer	SSELL	2,937	$0.4427	$1.3K	-1.7%	Open the original filing on SEC.gov
May 16, 2025	Higa Tomohiro	SVP, Finance	SSELL	1,390	$0.4427	$615	-1.4%	Open the original filing on SEC.gov
May 16, 2025	Ali Faraz	Chief Executive Officer	SSELL	3,189	$0.4427	$1.4K	-1.0%	Open the original filing on SEC.gov

AGRANT◆—

Tingley Whittemore · Chief Medical…Sep 10

293,000 sh

AGRANT—

Tingley Whittemore · Chief Medical…Sep 10

49,000 sh · +22.9% own

AGRANT◆—

Ali Faraz · Chief Executive…Sep 10

732,500 sh

AGRANT—

Ali Faraz · Chief Executive…Sep 10

122,000 sh · +29.2% own

SSELL$5.3K

Ali Faraz · Chief Executive…Aug 17

7,406 sh @ $0.7097 · -1.7% own

SSELL$3.6K

Ali Faraz · Chief Executive…Aug 17

5,020 sh @ $0.7097 · -1.2% own

SSELL$2.8K

Ali Faraz · Chief Executive…Aug 17

3,969 sh @ $0.7098 · -0.9% own

SSELL$4.1K

Ali Faraz · Chief Executive…Aug 17

5,837 sh @ $0.7097 · -1.3% own

SSELL$1.6K

Tingley Whittemore · Chief Medical…Aug 17

2,279 sh @ $0.7098 · -1.1% own

SSELL$1.3K

Tingley Whittemore · Chief Medical…Aug 17

1,871 sh @ $0.7098 · -0.9% own

SSELL$1.2K

Tingley Whittemore · Chief Medical…Aug 17

1,637 sh @ $0.7098 · -0.7% own

SSELL$1.2K

Tingley Whittemore · Chief Medical…Aug 17

1,637 sh @ $0.7098 · -0.7% own

AGRANT◆—

Hyllengren Eric J · Chief Financial…Jul 13

1.7M sh

AGRANT◆—

Williams R Sanders · DirectorMay 28

120,000 sh

AGRANT◆—

Walsh Jeffrey T. · DirectorMay 28

120,000 sh

AGRANT◆—

Stehman-Breen Catherine · DirectorMay 28

120,000 sh

AGRANT◆—

Srivastava Deepak · DirectorMay 28

120,000 sh

AGRANT◆—

Parschauer Karah Herdman · DirectorMay 28

120,000 sh

AGRANT◆—

Lee June · DirectorMay 28

120,000 sh

AGRANT◆—

Burroughs Amy L. · DirectorMay 28

120,000 sh

SSELL$2.5K

Tingley Whittemore · Chief Medical…May 18

3,121 sh @ $0.7936 · -1.4% own

SSELL$1.2K

Higa Tomohiro · SVP, FinanceMay 18

1,485 sh @ $0.7932 · -1.2% own

SSELL$2.7K

Ali Faraz · Chief Executive…May 18

3,390 sh @ $0.7934 · -0.8% own

SSELL$1M

Column Group III Gp, Lp · 10% OwnerFeb 25

1.9M sh @ $0.5624 · -100.0% own

SSELL$927.6K

Column Group III Gp, Lp · 10% OwnerFeb 25

1.6M sh @ $0.5624 · -100.0% own

SSELL$214.9K

Column Group III Gp, Lp · 10% OwnerFeb 24

349,212 sh @ $0.6153 · -15.8% own

SSELL$190.3K

Column Group III Gp, Lp · 10% OwnerFeb 24

309,228 sh @ $0.6153 · -15.8% own

SSELL$96.9K

Column Group III Gp, Lp · 10% OwnerFeb 23

162,291 sh @ $0.5972 · -6.8% own

SSELL$85.8K

Column Group III Gp, Lp · 10% OwnerFeb 23

143,709 sh @ $0.5972 · -6.8% own

SSELL$170.8K

Column Group III Gp, Lp · 10% OwnerFeb 20

277,769 sh @ $0.6149 · -10.5% own

SSELL$151.2K

Column Group III Gp, Lp · 10% OwnerFeb 20

245,965 sh @ $0.6149 · -10.5% own

SSELL$1.2K

Tingley Whittemore · Chief Medical…Feb 17

1,876 sh @ $0.6431 · -0.9% own

SSELL$1.1K

Tingley Whittemore · Chief Medical…Feb 17

1,642 sh @ $0.6432 · -0.7% own

SSELL$1.1K

Tingley Whittemore · Chief Medical…Feb 17

1,642 sh @ $0.6432 · -0.7% own

SSELL$1.3K

Higa Tomohiro · SVP, FinanceFeb 17

2,022 sh @ $0.6431 · -1.7% own

SSELL$538

Higa Tomohiro · SVP, FinanceFeb 17

836 sh @ $0.6434 · -0.7% own

SSELL$393

Higa Tomohiro · SVP, FinanceFeb 17

611 sh @ $0.6434 · -0.5% own

SSELL$3.2K

Ali Faraz · Chief Executive…Feb 17

5,032 sh @ $0.643 · -1.1% own

SSELL$2.6K

Ali Faraz · Chief Executive…Feb 17

3,979 sh @ $0.6431 · -0.9% own

SSELL$3.8K

Ali Faraz · Chief Executive…Feb 17

5,851 sh @ $0.643 · -1.3% own

SSELL$1.5M

Column Group III Gp, Lp · 10% OwnerFeb 11

2.2M sh @ $0.6808 · -44.8% own

SSELL$1.3M

Column Group III Gp, Lp · 10% OwnerFeb 11

1.9M sh @ $0.6808 · -44.8% own

SSELL$148.8K

Column Group III Gp, Lp · 10% OwnerFeb 10

182,295 sh @ $0.8161 · -3.7% own

SSELL$131.7K

Column Group III Gp, Lp · 10% OwnerFeb 10

161,422 sh @ $0.8161 · -3.7% own

AGRANT◆—

Tingley Whittemore · Chief Medical…Feb 3

318,500 sh

AGRANT—

Tingley Whittemore · Chief Medical…Feb 3

48,750 sh · +27.9% own

AGRANT◆—

Higa Tomohiro · SVP, FinanceFeb 3

175,500 sh

AGRANT—

Higa Tomohiro · SVP, FinanceFeb 3

29,250 sh · +31.1% own

AGRANT◆—

Ali Faraz · Chief Executive…Feb 3

952,250 sh

AGRANT—

Ali Faraz · Chief Executive…Feb 3

158,600 sh · +52.9% own

SSELL$3.8K

Tingley Whittemore · Chief Medical…Nov 17, 2025

2,877 sh @ $1.33 · -1.7% own

SSELL$1.8K

Higa Tomohiro · SVP, FinanceNov 17, 2025

1,367 sh @ $1.33 · -1.4% own

SSELL$4.2K

Ali Faraz · Chief Executive…Nov 17, 2025

3,126 sh @ $1.33 · -1.0% own

SSELL$2.3K

Tingley Whittemore · Chief Medical…Aug 18, 2025

1,837 sh @ $1.25 · -1.1% own

SSELL$2K

Tingley Whittemore · Chief Medical…Aug 18, 2025

1,608 sh @ $1.25 · -0.9% own

SSELL$2K

Tingley Whittemore · Chief Medical…Aug 18, 2025

1,608 sh @ $1.25 · -0.9% own

SSELL$2.2K

Higa Tomohiro · SVP, FinanceAug 18, 2025

1,722 sh @ $1.25 · -1.8% own

SSELL$898

Higa Tomohiro · SVP, FinanceAug 18, 2025

717 sh @ $1.25 · -0.7% own

SSELL$655

Higa Tomohiro · SVP, FinanceAug 18, 2025

523 sh @ $1.25 · -0.5% own

SSELL$6.2K

Ali Faraz · Chief Executive…Aug 18, 2025

4,920 sh @ $1.25 · -1.6% own

SSELL$4.9K

Ali Faraz · Chief Executive…Aug 18, 2025

3,893 sh @ $1.25 · -1.3% own

SSELL$7.2K

Ali Faraz · Chief Executive…Aug 18, 2025

5,720 sh @ $1.25 · -1.8% own

AGRANT◆—

Walsh Jeffrey T. · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Williams R Sanders · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Stehman-Breen Catherine · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Srivastava Deepak · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Parschauer Karah Herdman · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Lee June · DirectorMay 29, 2025

107,400 sh

AGRANT◆—

Goeddel David V · Director, 10%…May 29, 2025

107,400 sh

AGRANT◆—

Burroughs Amy L. · DirectorMay 29, 2025

107,400 sh

SSELL$1.3K

Tingley Whittemore · Chief Medical…May 16, 2025

2,937 sh @ $0.4427 · -1.7% own

SSELL$615

Higa Tomohiro · SVP, FinanceMay 16, 2025

1,390 sh @ $0.4427 · -1.4% own

SSELL$1.4K

Ali Faraz · Chief Executive…May 16, 2025

3,189 sh @ $0.4427 · -1.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 29 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →